| Dr Jagruti Patel, MD | |
|
75 Herrick St, Parkhurst Building, Beverly, MA 01915-5900 | |
| (978) 927-6556 | |
| Not Available |
| Full Name | Dr Jagruti Patel |
|---|---|
| Gender | Female |
| Speciality | Plastic Surgery |
| Location | 75 Herrick St, Beverly, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770537151 | NPI | - | NPPES |
| 0144231 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 202942 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jagruti Patel, MD 75 Herrick St, Parkhurst Building, Beverly, MA 01915-5900 Ph: (978) 927-6556 | Dr Jagruti Patel, MD 75 Herrick St, Parkhurst Building, Beverly, MA 01915-5900 Ph: (978) 927-6556 |
News Archive
Bristol-Myers Squibb and Pfizer announced today that the European Commission has approved ELIQUIS (apixaban) for prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors.
Cancer immunotherapy is showing promise in treating patients with a variety of advanced, metastatic tumors, as evidenced by two newly unveiled studies from Yale Cancer Center.
Published in the Journal Proceedings of the National Academy of Sciences, senior author, Associate Professor Katherine Kedzierska from the Department of Microbiology and Immunology said that being able to predict which patients will be more susceptible to the emerging influenza strain, will allow clinicians to better manage an early intervention strategy.
The US National Institutes of Health (NIH) has awarded a $2.1 million "Grand Opportunity" (GO) grant to a team of researchers - led by Prof. Todd Lencz at the Feinstein Institute for Medical Research, New York, and Prof.Ariel Darvasi of the Silberman Institute of Life Sciences at the Hebrew University of Jerusalem - to conduct a study on the genetic basis of schizophrenia..
Elcelyx Therapeutics announced today that clinical study results confirm that the primary site of action of Type 2 diabetes medicine metformin is in the lower bowel rather than in the circulation.
› Verified 4 days ago
Anoush Hadaegh, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 900 Cummings Ctr, Suite 301u, Beverly, MA 01915 Phone: 413-222-2292 | |
Dr. Mahesh Patel, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 75 Herrick St, Suite 105, Beverly, MA 01915 Phone: 978-927-6556 | |
Dr. Mary Catherine Hertl, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 900 Cummings Ctr, Ste 216t, Beverly, MA 01915 Phone: 978-969-2081 Fax: 978-969-2084 |